BCAA-BCKA axis regulates WAT browning through acetylation of PRDM16
BCAA-BCKA axis regulates WAT browning through acetylation of PRDM16
复制标题
BCAA–BCKA 轴通过 PRDM16 乙酰化调节 WAT 褐变
DOI:
10.1038/s42255-021-00520-6
复制
发表时间:
2022-01-24
影响因子:
20.8
通讯作者:
Lei, Qun-Ying
中科院分区:
文献类型:
--
作者:
Ma, Qi-Xiang;Zhu, Wen-Ying;Lei, Qun-Ying
The link between branched-chain amino acids (BCAAs) and obesity has been known for decades but the functional role of BCAA metabolism in white adipose tissue (WAT) of obese individuals remains vague. Here, we show that mice with adipose tissue knockout of Bcat2, which converts BCAAs to branched-chain keto acids (BCKAs), are resistant to high-fat diet-induced obesity due to increased inguinal WAT browning and thermogenesis. Mechanistically, acetyl-CoA derived from BCKA suppresses WAT browning by acetylation of PR domain-containing protein 16 (PRDM16) at K915, disrupting the interaction between PRDM16 and peroxisome proliferator-activated receptor-γ (PPARγ) to maintain WAT characteristics. Depletion of BCKA-derived acetyl-CoA robustly prompts WAT browning and energy expenditure. In contrast, BCKA supplementation re-establishes high-fat diet-induced obesity inBcat2knockout mice. Moreover, telmisartan, an anti-hypertension drug, significantly represses Bcat2 activity via direct binding, resulting in enhanced WAT browning and reduced adiposity. Strikingly, BCKA supplementation reverses the lean phenotype conferred by telmisartan. Thus, we uncover the critical role of the BCAA–BCKA axis in WAT browning.